Dicarbonyl compounds react more rapidly, than glucose, with arginine and lysine in proteins to form advanced glycation end products (AGEs) and further produce free radicals which cause DNA damage. AGEs are reliable diagnostic biomarkers for most of the age-related diseases. In the present study histone was modified with glyoxal and it was characterized by various spectral techniques. Binding characteristics of the modified histone towards serum antibodies from type 1 diabetes patients was evaluated by solid phase enzyme immunoassay and the results were compared with normal human subjects. Fluorescence and Fourier transformed infrared analysis of the nuclear protein clearly indicated changes in their respective intensities upon modification with glyoxal. Liquid chromatography together with mass spectrometry showed new peaks and m/z values related to AGE adducts of dihydroimidazolidines/hydroimidazolones. This glyoxal modified protein was recognized by serum antibodies of the diabetes patients while it showed negligible binding with that of normal human subjects. Glyoxal modification of histone causes structural turbulence and formation of advanced glycation adducts in histone. These adducts might be the main antigenic epitope of the modified histone, leading to its recognition by circulating type 1 diabetes antibodies.
Introduction
Reactive carbonyl species (RCS), like glyoxal, are produced by autoxidation of glucose, early protein glycation adducts, degradation of lipid peroxidation products, and as a byproduct of glycolysis. The presence of carbonyl groups in histones could have important implications for the maintenance of genomic integrity (Wondrak et al. 2000) . Glyoxal or methylglyoxal reacts mainly with guanidine group of arginine residues to form their prominent advanced glycation end product (AGE) as hydroimidazolones (Supplementary Figure) (Chen et al. 2015) . This reaction first produces AGE, glyoxal derived dihydroxyimidazolidine (G-DH) (Glomb and Monnier 1995; Thornalley et al. 2003 ) as a precursor of glyoxal derived hydroimidazolones (G-H1), while other AGEs are argpyrimidine (AP) from methylglyoxal and Nε-(carboxymethyl)arginine (CMA) from glyoxal (Iijima et al. 2000) . Nε-(carboxyethyl)lysine (CEL) and Nε-(carboxymethyl)lysine (CML) are AGEs produced from methylglyoxal and glyoxal, respectively, on reaction with lysine residues. Concentration of hydroimidazolone is higher in cellular protein than in plasma protein and they are present at higher concentration than CML on these proteins (Thornalley et al. 2003) . Hydroimidazolone are important AGEs in proteins glycated in vitro ) with a moderate chemical stability under physiological conditions, degrading to the corresponding dicarbonyls and arginine beside other products . Proteome analysis showed that hydroimidazolone induced modification may involve about 26% cellular proteins as mean number of arginine residues per protein is 26 (Pruess et al. 2003) . Glyoxal reacts with both free and peptide bound arginine residues and half life of its product, G-H1 is much higher than that derived from methylglyoxal and 3-deoxyglucosone.
Earlier studies have shown AGE-modified histones in diabetic rats (Gugliucci and Benayan 1995) and in liver cells of diabetic patients (Jobst et al. 1991) . Induced antibodies against AGEmodified BSA reacted with both lysine-derived and arginine-derived glycation products (Choi and Lim 2009) . Most of the previous studies have focused on AGEs, derived from sugar (pentoses, hexoses or their derivatives) modified proteins and especially on CML, derived from lysine residues. Arginine residues are more reactive with glyoxal in thiol-free solutions when compared to lysine and cysteine (Schwarzenbolz et al. 2008) . Important investigations done on glyoxal and methylglyoxal reacted ribonuclease indicated that arginine residues, mainly Arg-39 and Arg-85, are the main sites of AGEadducts formation (Cotham et al. 2004; Brock et al. 2007 ). In view of the above studies, this work revealed physicochemical analysis of histone protein upon modification with glyoxal, involving an insight into advanced glycation adducts and recognition of this glycated histone by serum antibodies of type 1 diabetes mellitus (type 1 DM) patients.
Results
Glyoxal modified histone (GO-histone) was characterized by various spectral techniques and enzymatic immunoassay, summarized in Table I. AGE-specific fluorescence of GO-histone AGE formation in modified histone was determined by excitation at AGE-specific fluorescence of 335 nm ( Figure 1A ). It showed an increase in fluorescence intensity with a shift in the wavelength of maximum emission when compared to the native histone. The increase in intensity was 36.4% at 407 nm (1 mM glyoxal) and 62.5% at 405 nm (2 mM glyoxal), compared to native histone (max. emission at 427 nm). However, the intensity enhancement was 49.3% at 406 nm and 64.7% at 404 nm with 1 and 2 mM glyoxal, relative to native histone (max. emission at 419 nm), when excitation was 320 nm (data not shown). The sample of histone incubated with 1 mM glyoxal for 24 h was used for further analysis.
Amide band analysis by Fourier transformed infrared
Conformational changes in histone were determined by position and intensity of amide bands in Fourier transformed infrared (FT-IR) absorption spectra ( Figure 1B ). There was shift in position and decrease in intensity of two bands, amide I (1600-1700 cm −1 ) and i and ii represent 1 and 2 mM concentration, respectively, of the histone modifier. ) in GO-histone with respect to native histone at pH 7.4. Native histone was characterized by an intense band at 1641 cm −1 and a weak one at 1622 cm
. These bands were shifted to 1639 and 1607 cm −1 , respectively, together with appearance of a new band at 1673 cm −1 in GO-histone. Similar changes were observed in amide II bands of modified histone, in relation to the native form.
Detection of new peak and m/z values in GO-histone by LC-MS
Evolutions of new and prominent chromatographic peaks were observed in modified histone. These significant peaks were at retention time (RT) of 7.3, 22.1, 23.5 and 26.05 ( Figure 2A ). Only a single chromatographic peak with RT of 6.3 was found in native histone (inset of Figure 2A ). The small peak at RT 7.3 was associated with the peak at RT 6.4 in modified histone. LC-MS spectra of GO-histone also revealed characteristic ions at m/z values in the range of 600-1000, especially with high abundance at 717, 740 and 900 ( Figure 2B ), and these were absent in the spectra of untreated histone (inset of Figure 2B ).
Recognition of GO-histone by serum antibodies of type 1 DM GO-histone was significantly recognized by a majority of 21 samples of different sera from the diabetic patients in comparison to native histone (P < 0.001), as it showed increase in absorbance of 68.6%, at 1:100 serum dilution in direct binding ELISA ( Figure 3A ). There was no significant recognition of either histone samples by sera of normal humans. Specific binding of GO-histone by serum samples of these patients was evaluated by competition ELISA. Native, GOhistone and GO-HSA at maximum concentration of 20 μg/mL, were used as inhibitors to determine the specific binding. Serum samples from the three patients showed higher reactivity with GO-histone in contrast to GO-HSA and native histone as revealed by high percent inhibitions with GO-histone ( Figure 3B ). Other serum samples also showed high percent inhibitions with modified histone compared to native histone (P < 0.001) (Table II) . Average percent inhibition in the binding of GO-histone to the antibodies in diabetic sera was higher by 15.5 and 65.8% in relation to GO-HSA and native histone, respectively. Structure of G-H1 is shown in inset of Figure 3B .
Discussion
Glyoxal levels are much lower than glucose in plasma but it is far more reactive. Concentration of CML and Nε-(carboxyethyl)lysine (CEL) residues were 10-100-fold lower than dicarbonyl derived AGEs in plasma and urine (Thornalley et al. 2003) . Histone protein is rich in both lysine and arginine residues, so we have chosen it to see the effect of glyoxal towards these residues and its role-in-type 1 DM. We have shown glyoxal induced aggregation in histone by electrophoresis and effect of the carbonyl scavengers on GO-histone (Ansari and Dash 2013) . Low concentration of RCS binds to histone and rapidly forms dimers and polymers, which have reduced mobility in electrophoresis (Talasz et al. 2002) .
In the present study we modified histone with glyoxal and their structural characterization was done by various spectral techniques. Results of the analysis clearly showed glyoxal-derived AGE-adducts in the glycated histone. Fluorescence analysis of modified histone indicated increase in intensity at 404-407 nm in relation to native histone. Further increase in the level of intensity at the specified wavelength occurs when we increase concentration of modifier from 1 to 2 mM. AGE adducts of arginine residues in glycated proteins is determined by AGE-specific absorbance at 330 nm and by AGEspecific fluorescence emission wavelength between 405 and 410 nm (Schmitt et al. 2005) .
FT-IR absorption spectra showed position and intensity of amide bands in native and GO-histone. Amide I bands are considered as a sensitive probe for assessment of protein secondary structure. In native histone, amide I bands at 1641 and 1622 cm −1 corresponded to random and pleated sheet structures respectively (Shestopalov and Chirgadze 1976) . The shifting and decrease in intensity of amide I bands in modified histone reflect secondary structure changes in the nuclear protein upon treatment with glyoxal.
Results of liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) analysis clearly showed new chromatographic peaks with their specific RT and their characteristic ions at specific m/z in GO-histone. Peak with RT 6.3 in native histone is related to lysine while small peak with RT 7.3 in modified histone corresponded to CML (Thornalley et al. 2003) . New and intense peaks with RT 22.1, 23.5 and 26.05 in modified histone are related to the chromatographic peaks obtained upon modifications in different arginine residues of RNase by glyoxal (Cotham et al. 2004) . These modifications are shown to be caused by AGE adducts of G-DH and G-H. Appearance of prominent ions at m/z 717, 740 and 900 in GO-histone corresponded to that of G-DH/CMA mentioned in the previous investigation (Cotham et al. 2004 ). Interestingly, these glyoxal induced major AGE-adducts of arginine residues were not found in RNase incubated with glucose (Brock et al. 2003 ). This analysis also revealed low preference of glyoxal towards lysine to form CML as major adducts in presence of arginine in histone which is in conformity with the earlier investigation determining glyoxal orientation towards arginine residues in cellular and plasma proteins despite containing higher lysine content (Thornalley et al. 2003) . Presence of less abundant and higher mass ions at m/z 919, 1020, 1188 and 1224 in native histone is due to trace of contaminants which were exposed after enhancing sensitivity in order to show for the absence of AGE-adducts. This is the first report for the reactivity of antibodies in diabetic sera towards glyoxal-mediated glycated histone, enriched with arginine-derived AGE-adducts. AGE-adducts of G-H1 is suggested to be the main antigenic epitope structure of the antibodies. An earlier study used induced antibodies against methylglyoxal modified ribonuclease A to identify proteins modified with different glycating agents including glyoxal and found that the major antigenic epitopes for the antibodies were modified arginine residues (Shamsi et al. 1998) . A recent study has shown in vivo formation of RCSmediated AGE-adducts in histone H 1 by using antibodies against CML and argpyrimidine (Pashikanti et al. 2011) . Previous investigations have studied other supporting aspects of RCS targeted AGE adducts on intracellular and extracellular proteins. Earlier, no reliable measurement of physiological concentrations of RCS was possible, with the problem of overestimation due to its production from various compounds. However, it has been found that normal plasma level of glyoxal is 215-230 nM which increases to 350-470 nM in diabetes (Lapolla et al. 2003a (Lapolla et al. , 2003b and cellular concentration of glyoxal and methylglyoxal are 0.1-1 and 1-5 μM, respectively (Dobler et al. 2006) . High levels of G-H1 were found in the proteins of retina, nerve and plasma proteins of diabetic rats (Cotham et al. 2004) . Hydroimidazolone AGEs are found in highest concentrations in lens protein of old-aged humans (Thornalley 2008) . It causes structural distortion, loss of side chain charge and functional impairment of proteins and studied extensively on MG-H1 adducts in arginine residues of human serum albumin (Ahmed et al. 2005) . CMA was also found in serum proteins of diabetic patients (Odani Mera et al. 2008 ) and the monoclonal antibody used to detect CMA only reacted with CMA and CMA-protein adducts but not cross-reacted with CML and S-(carboxymethyl)cysteine. It is well known that glycation-led damaged proteins are resistance to proteolysis due to covalent crosslinking of proteins but the protein is also damaged when the modified amino acids occur in functional site of these proteins. Since arginine residues have high-frequency occurrence in sites of protein-protein interaction, enzyme substrate interaction and protein-DNA interaction (Gallet et al. 2000) and they are preferentially glycated by dicarbonyls, causing functional impairment in these proteins associated with aging, metabolic and neurological disorders (Rabbani and Thornalley 2008) .
Conclusions
The study on spectral analysis of GO-histone revealed structural changes in native histone. This perturbation leads to formation of AGE adducts in histone and recognition of the glycated histone by serum antibodies of type 1 diabetes patients. AGE adducts indicated mainly towards glyoxal-derived hydroimidazolones which might be the prominent antigenic epitope of histone, triggering production of antibodies in diabetes patients. This modification can be a potential target for designing inhibitor to prevent dicarbonylation of many proteins associated with diabetic complications and other agerelated diseases.
Materials and methods

Reagents
Calf thymus whole histones (type II-A), glyoxal, anti-human IgGalkaline phosphatase conjugate and p-nitrophenyl phosphate were purchased from Sigma (St. Louis, MO). Polystyrene flat bottom microtiter plates were purchased from Greiner BioOne (Germany). All other reagents/chemicals were of highest analytical grade.
Collection of blood samples from human subjects
Blood samples of 34 donors with history of type 1 DM were collected from Sir Sunderlal Hospital, IMS, BHU, Varanasi, India. Control samples were collected from 20 normal healthy subjects. All the diseased and healthy persons gave their prior informed consent. The study had the required ethical approval.
Modification of histone
Histone was glycated by modifying histone with glyoxal as previously described with slight modifications (Roberts et al. 2003; Gugliucci et al. 2009 ). Briefly, histone (1 mg/mL) was incubated with 1 and 2 mM glyoxal for 24 h at 37°C in 0.25 M sodium phosphate buffer (pH 7.4). Histone incubated, without glyoxal, in the same condition termed as native histone.
Fluorescence measurements
Fluorescence characteristics of the histone samples were observed on a spectrofluorophotometer (Hitachi, model F-2500) with slit width fixed at 10 nm. Fluorescence spectra were recorded at 25 ± 0.1°C in a 1 cm path length cuvette. Presence of AGE-adducts in modified histone was obtained by AGE-specific fluorescence at 335/385 nm (λ ex /λ em ) (Gugliucci and Benayan 1995) and compared with that of native histone. Percent modification in fluorescence intensity (FI%) was calculated using the following equation:
FT-IR analysis
GO-histone was further analyzed on Nicolet 5700 FT-IR spectroscope (Thermo Corporation) at room temperature. Absorption spectra were recorded in the range from 1500 to 1700 cm −1 with a resolution of 4 cm −1
. Automated spectra of the samples were obtained using the following equation:
Spectra of native histone native buffer buffer
Spectra of modified histone native modified buffer native buffer .
Liquid chromatography-electrospray ionization-mass spectrometry LC-ESI-MS of GO-histone was conducted on Thermo Finnigan LCQ Advantage max ion trap mass spectrometer having Finnigan Surveyor HPLC system connected to it. The spectra obtained were compared to that of native histone. The column was thermo BIOBASIC-C18, 100 × 1, 5 μm and solvent was eluted as given gradient program at 40 μL/min. A 5 μl sample was introduced into the ESI source through Finnigan surveyor autosampler. Ion spray voltage was set at 5.3 KV and capillary voltage 40 V. MS spectra were scanned in the range 200-2000 m/z and the maximum ion injection time was set 500 nS. Final spectra are averaged of over 1-6 scan at peak top in TIC. The data reductions were performed by using Xcalibur 1.4 SR1 and mass spectrum was deconvoluted on Bioworks 3.1SR1.
Direct binding ELISA
It was used to detect antibodies against GO-histone in the sera of type 1 DM. ELISA was carried out on polystyrene microtitre plates as described previously (Ali and Alam 2002) with slight modification. The plates were coated with 100 μL of native or glyoxal modified histone (10 μg/mL). Absorbance (A) of each sample was recorded on an automatic microplate reader at 410 nm. Average absorbance of native/modified histone was calculated as mean of A test -A control .
Results were expressed as follows: Competition ELISA Antigen binding specificity of the antibodies was evaluated by this assay (Dixit and Ali 2001) . Microtitre plates were coated with 100 μL of GO-histone (10 μg/mL). Different concentration of inhibitor (0-20 μg/mL) was mixed with a constant level of test serum. This mixture was incubated at room temperature for 2 h and overnight at 4°C. Samples containing immune complex thus formed was added in the wells. Remaining steps were performed according to direct binding ELISA. Percent inhibition was calculated using the following formula: 
Statistical analysis
Data are shown as mean ± SD. A value of P < 0.05 was considered significant.
Supplementary data
Supplementary data is available at Glycobiology online. 
